crackdown on glp 1 meds GLP-1 Drug Prices Plummet Amid Government | Dr Rajiv Kumar Jain posted the topic FDA to Restrict Ingredients Used

PNAS Nexus 4 , pgaf042 (2025)

Tirzepatide medications like Zepbound and Mounjaro are once-weekly injectables

States that have recently cut or restricted GLP-1 coverage for weight loss include: North Carolina (ended coverage October 2025) California, New Hampshire, and South Carolina (ending coverage January 2026) Pennsylvania (restricting coverage to non-weight-loss indications) Michigan (limiting to morbidly obese patients only) The BALANCE model will open to state Medicaid agencies as early as May 2026, which could eventually bring more uniform pricing and access

For instance, t 1/2 values could not be derived because plasma L-carnitine concentrations remained relatively stable over 48 h

Q: What are the therapeutic uses of Glutathione Injection

While these substances are gaining popularity, it's crucial to recognize the significant risks they pose